Canada phê duyệt vaccine COVID-19 đầu tiên được sản xuất trong nước

Bộ Y tế Canada ngày 24/2 đã cấp phép sử dụng đối với Covifenz - một loại vaccine phòng COVID-19 do hãng công nghệ sinh học Medicago sản xuất tại Canada. Loại vaccine hai liều này có nguồn gốc từ thực vật, được phép sử dụng cho những người từ 18 đến 64 tuổi.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Thế giới
(Baothanhhoa.vn) - Theo thông báo của Bộ Tài chính Israel, chi phí từ xung đột giữa Israel và Iran đang gia tăng nhanh chóng, với ước tính chi phí trực tiếp từ xung đột với Iran kể từ cuối tháng 2/2026 đã lên tới khoảng 35 tỷ shekel (tương đương 11,5 tỷ USD).
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh